Home / Guides / By state / Tirzepatide in Maryland
Maryland rules, read closely.
Best tirzepatide providers in Maryland, 2026
By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated
NexLife publishes this guide and is one of the programs in it. Every program, ours included, faces the same tests, and every price links to its source.
Maryland Medicaid covers Zepbound only for sleep apnea, not weight loss; online programs charge $139 to $399 monthly for compounded tirzepatide (checked November 1, 2026). NexLife charges $139 a month on its 12-month plan, or $169 month to month, whatever the dose.
$139/mo on 12 months, every dosePrice Match Guarantee†
- Maryland Medicaid covers Zepbound for sleep apnea, not weight loss
- A 2026 law lets Medicaid add obesity care from 2027
- Nonresident pharmacies must name a Maryland-licensed pharmacist

$139/mo on a 12-month plan, all-inclusive, same price at every dose
Or $169/mo month to month
About 3 minutes of health questions · No insurance needed · Not prescribed? No charge for medication
4.8 out of 5 on Trustpilot, 407 reviewsLegitScript-certified
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. The vial shown is an illustration. Always use the strength on your pharmacy’s label.
See all 4 plans and what a year costs
| Plan | Per month | 12 months at this rate |
|---|---|---|
| 12-month Lowest monthly price | $139 | $1,668 |
| 6-month | $149 | $1,788 |
| 3-month | $159 | $1,908 |
| Month to month | $169 | $2,028 |
Month to month costs $360 more over 12 months than the 12-month plan. Plans renew until you cancel. Longer plans bill the way you choose at checkout.
Price Match Guarantee†. Paying less elsewhere? We match your regular monthly price. How it works
- Licensed U.S. providers
- LegitScript certified
- Free expedited shipping
- HSA, FSA, Affirm, Klarna, Afterpay
- 24/7 support, real people
- Filled by Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA)
All 10 at a glance, A to Z
- Hims24/7 provider messagingFrom $448with membership
- LillyDirectZepbound at Lilly’s price$299–$449per 28-day supply ($449 needs a refill within 45 days; otherwise $499–$699)
- Mochi HealthObesity-medicine doctors$169/moat the lowest dose
- NexLifePublisher of this guide$139–$169/mo12 months · month to month
- NoomMost coaching$299/moafter a $149 first month
- Ondra HealthPlan lengths from 1 to 12 months$219/momonth to month
- PreventiveMDMonth to month, no membership fee$139/momonth to month
- Remedy MedsUnlimited clinician access$399every 4 weeks
- RoInsurance checks$448–$598with membership
- Rx.comNo automatic renewals$285/momonth to month
Listed A to Z, each with its own published price; NexLife publishes this guide and doesn’t rank itself.
Comparing programs nationally? See the best tirzepatide providers online, compared side by side with prices and check dates.
- Tell us about you About 3 minutes of health questions
- A licensed provider decides You’re prescribed only if it’s right for you
- Your partner pharmacy ships Usually within 1 to 2 business days, free
Key takeaways
- Maryland Medicaid doesn’t cover Zepbound for weight loss (checked November 2, 2026).
- Maryland’s state employee plan doesn’t cover
GLP-1 drugs for weight loss. - Your prescriber needs a Maryland license to treat you there.
- Compounded tirzepatide costs $139 to $399 a month online in our price index, all in (median $237, checked November 1, 2026).
- Check before you pay: confirm the prescriber’s Maryland license and the pharmacy’s; the steps are below.
- At NexLife: $139 a month on the 12-month plan, the same at every dose.
At a glance
Tirzepatide in Maryland: the short answers
| Question | Answer |
|---|---|
| Maryland Medicaid | Not covered for weight loss |
| The state employee plan | State Employee and Retiree Health and Welfare Benefits Program: not covered for weight loss |
| Who can prescribe it | A provider licensed in Maryland |
| Compounded tirzepatide, without insurance | $139 to $399 a month online in our price index, all in (median $237, checked November 1, 2026) |
| At NexLife | $139 a month on the 12-month plan, or $169 month to month, the same at every dose |
Picks
Which tirzepatide provider is best for you?
Online tirzepatide programs, by what each does best and its catch. Prices are each program’s online price in our price index (checked November 1, 2026); check that a program serves Maryland before you pay.
| Best for | Program | Price | The catch |
|---|---|---|---|
| Publisher of this guide | NexLife | $139 a month on the 12-month plan; $169 month to month; the same at every dose, no membership fee | Cancel by email, effective 30 days after NexLife receives it |
| Lowest month-to-month price in our index | PreventiveMD | $139 a month at every dose, no membership fee | Its prepaid 3- to 12-month rates aren’t in our index |
| Lowest 12-month price in our index | Cora | $135 a month, $1,620 paid upfront | You pay for all 12 months upfront |
| Obesity-medicine doctors | Mochi Health | $169 at the lowest dose, its $79 membership included | The price rises with your dose |
| FDA-approved Zepbound | LillyDirect | $299 to $449 a month, by dose | $449 needs a refill within 45 days, or it’s $499 to $699 |
Coverage
Does insurance cover tirzepatide in Maryland?
Each kind of plan in Maryland: what it covers for weight loss, with its source.
| Your plan | For weight loss | What to know |
|---|---|---|
| Maryland Medicaid Maryland Medical Assistance Program | Not covered for weight loss | Not for weight loss alone. Since Feb. 5, 2025, Maryland Medicaid has covered Zepbound with prior authorization for adults with obesity (BMI 30 or more) and moderate to severe obstructive sleep apnea confirmed by a sleep test. A sleep specialist, pulmonologist or other experienced provider must prescribe or consult. (source) |
| State employees State Employee and Retiree Health and Welfare Benefits Program | Not covered for weight loss | No. Maryland's state employee and retiree prescription plan lists weight loss drugs among its exclusions in both its 2026 and 2027 benefit guides. |
| Job-based and marketplace plans | Depends on the plan | Ask HR or your plan: Are Zepbound and Wegovy covered for weight loss? Is prior authorization required? Which BMI or conditions qualify? If your plan is subject to Maryland law, you may be able to complain to the Maryland Insurance Administration after the plan's appeal. (source) |
| Medicare Part D | $50 a month, if you qualify | Medicare’s |
| TRICARE | Prime and Select: in certain circumstances | TRICARE Prime and Select still cover weight-loss medications in certain circumstances. TRICARE For Life has been excluded since August 31, 2025. TRICARE |
| No insurance | You pay cash | Compounded tirzepatide costs $139 to $399 a month online in our price index, all in (median $237, checked November 1, 2026). At NexLife, it’s $139 a month on the 12-month plan, or $169 month to month, the same at every dose. |
If your plan says no. If a plan subject to Maryland law denies a drug as not medically necessary, appeal to the plan, then complain to the Maryland Insurance Administration within four months of its grievance decision. The Attorney General's Health Education and Advocacy Unit helps free. Plans outside Maryland law may still offer external review. (source)
State rules
What does Maryland law require before you get tirzepatide online?
Each rule, in plain words, with the law or board that sets it.
| Rule | What it means for you | Source |
|---|---|---|
| Getting care online | Maryland's Board of Physicians holds telehealth to the same standards of practice and documentation as in-person care. Before treating you or prescribing, the practitioner must do a clinical evaluation appropriate for you and your condition, and get your oral or written consent. The practitioner needs a Maryland license. Separate limits apply to opioid pain prescriptions. | Md. Code, Health Occ. §1-1003 (added by SB 402 of 2020); COMAR 10.32.05.06 (source) |
| Your prescriber’s license | Your doctor must hold a Maryland license. The Board of Physicians says physicians must be licensed in Maryland to treat patients here, including by telehealth, and a Maryland license covers telehealth for Maryland patients without further Board approval. Look it up. | (source) |
| Nurse practitioners and PAs | Nurse practitioners don't need a physician agreement, but new NPs must name a physician or NP mentor for their first 18 months. Physician assistants need a collaboration agreement with one or more patient care team physicians (since Oct. 1, 2024). | COMAR 10.27.07.02 (Chapter 468 of 2015, HB 999); Md. Code, Health Occ. §15-302 (PA Modernization Act of 2024) (source) |
| The pharmacy | A pharmacy outside Maryland needs a Maryland nonresident pharmacy permit and a Maryland-licensed pharmacist responsible for Maryland patients, plus a toll-free number. If it sends compounded sterile drugs, such as injections, here, it must follow USP standards and Maryland's sterile compounding rules, and apply with a sterile inspection report. Look it up. | Md. Code, Health Occ. §12-403; COMAR 10.34.37 (nonresident pharmacy operations); COMAR 10.34.19 (sterile compounding) (source) |
| Compounding, July 7, 2026 | In 2026, Maryland's Board of Pharmacy reprimanded and fined a Pennsylvania compounding pharmacy that shipped about 1,580 compounded sterile | Maryland Board of Pharmacy, Consent Order, Case No. 25-422B (source) |
Is it legal?
Is compounded tirzepatide legal in Maryland?
Yes, when a state-licensed 503A pharmacy prepares it for your prescription and your prescriber documents a significant difference for you. It isn’t FDA-approved. The FDA confirmed the tirzepatide shortage was resolved on December 19, 2024, so routine copies stopped. On August 27, 2026, the Fifth Circuit upheld that decision. The ruling. The FDA on compounding.
Maryland’s own compounding actions are in the rules table above, with their dates.
5-minute check
How do you check a Maryland pharmacy and prescriber?
- Ask the program, in writing, which pharmacy fills your prescription, or read the label: it names the pharmacy.
- Search that pharmacy on Maryland’s pharmacy license lookup. Check that its Maryland license or registration is active.
- Check the address on the license matches the address on your label.
- Look up your prescriber on the Maryland license search: a provider treating you in Maryland needs a Maryland license.
- Check the program on LegitScript’s public list of certified websites.
At NexLife, licensed providers prescribe, and two named partner pharmacies fill prescriptions: Absolute Pharmacy (Lutz, FL) and Boudreaux’s New Drug Store (Lake Charles, LA). We’re LegitScript-certified.
Timeline
What changed for tirzepatide in Maryland, and when?
Newest first, each with its source.
Earliest date Maryland Medicaid may offer comprehensive obesity treatment coverage under Chapter 866 (optional, not required). Maryland General Assembly
Chapter 866 (SB 496) takes effect, authorizing optional Medicaid obesity coverage from Jan. 1, 2027. Maryland General Assembly
Board of Pharmacy order reprimands and fines a nonresident pharmacy over compounded
GLP-1s shipped into Maryland (file date). Maryland Board of PharmacyMedicare
GLP-1 Bridge starts: eligible Part D enrollees pay $50 a month for Wegovy, Foundayo or the Zepbound KwikPen. Centers for Medicare & Medicaid Services (Medicare.gov)SB 496 is enacted as Chapter 866 of 2026. Maryland General Assembly
National: the FDA proposes keeping semaglutide, tirzepatide and liraglutide off the 503B bulks list. U.S. Food and Drug Administration
Maryland Medicaid begins covering Zepbound for adults with obesity and obstructive sleep apnea. Maryland Medical Assistance Program (copy posted by Aetna Better Health, a HealthChoice MCO)
Maryland's PA Modernization Act takes effect, replacing delegation agreements with collaboration agreements. Maryland Board of Physicians
Maryland prices
Maryland prices: coverage versus cash
Unless sleep apnea qualifies you for Medicaid coverage, most Maryland routes are cash routes. Zepbound is $299 to $449 a month at LillyDirect, by dose, and compounded tirzepatide, which isn’t FDA-approved, runs $139 to $399 online in our price index. LillyDirect’s $449 (7.5 to 15 mg) needs a refill within 45 days, or it’s $499 to $699. At NexLife it’s $139 a month on the 12-month plan or $169 month to month.
| Route | What it costs | The catch |
|---|---|---|
| Maryland Medicaid | Zepbound covered for sleep apnea, with prior authorization | Weight loss alone doesn’t qualify |
| State of Maryland employee plan | Weight-loss drugs excluded | Diabetes |
| Brand-name Zepbound (LillyDirect) | $299 to start, $399 at 5 mg, $449 at 7.5 mg or higher with a refill within 45 days ($499 at 7.5 mg and $699 at 10 to 15 mg otherwise) | FDA-approved; the medication only |
| Compounded tirzepatide in our index | $139 to $399 a month; median $237 | 14 online programs; not FDA-approved |
| Compounded tirzepatide through NexLife | $139 a month (12-month plan) or $169 (month to month) | No membership fee; care, coaching and shipping included |
Two compounded prices set the low end of our index: PreventiveMD at $139 month to month, and Mochi Health, which charges $169 at its lowest dose and more as the dose rises. Each of the 10 programs listed at the top of this page has a full, sourced review on our best tirzepatide providers online page.
Maryland Medicaid
The sleep apnea route to Zepbound on Maryland Medicaid
A prescriber documents five things on Maryland’s form (December 2025): a sleep study showing moderate to severe obstructive sleep apnea, a BMI of 30 or more from the last 90 days, a sleep specialist or similar expert involved, a 6-month weight management try without weight loss and no other
- A sleep study, in a lab or at home, showing moderate to severe obstructive sleep apnea: at least 15 breathing events an hour.
- A BMI of 30 or more, measured within the last 90 days.
- A prescription from, or in consultation with, a sleep specialist, a pulmonologist or another provider experienced in sleep apnea.
- Your prescriber’s signed statement that you tried weight management in the past 6 months without losing weight, and that you aren’t taking another
GLP-1 . - After the first 12 months, fresh documentation of moderate to severe sleep apnea every year.
Without sleep apnea, Maryland Medicaid won’t cover Zepbound for weight loss today. SB 496 lets the state add obesity treatment from January 1, 2027, but leaves the choice to the Department of Health.
State employees
What does the State of Maryland plan cover for tirzepatide?
Not weight loss. The 2026 Health Benefits Guide lists weight-loss drugs among its exclusions, so Zepbound for weight loss isn’t covered. Mounjaro, tirzepatide’s brand for type 2 diabetes, is a GIP/
Who decides. MedImpact Healthcare Systems runs the plan’s prescription benefit. Its prior authorization list can change during the year. The current list is posted at mymdbenefits.com, and MedImpact answers member questions at 1-844-348-8508.
Diabetes support. For members with diabetes, the plan’s MedEmpower Fuel benefit adds a glucometer, test strips and coaching.
What would you pay with NexLife?
Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.
Pick one above to see your price.
Prices from each provider’s own site, checked November 1, 2026. Brand-name and compounded medications are different products: compounded medications aren’t FDA-approved, and a provider prescribes one only when it offers a significant difference for you. Price Match Guarantee† terms apply.
Two medications.
One flat price at every dose.
No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†
GIP + 12-month plan $139/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.
Check my eligibilityCompounded, not FDA-approved · Not prescribed? No charge for medication

12-month plan $119/mo
Semaglutide
Weekly
Compounded, not FDA-approved · Not prescribed? No charge for medication
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms
The NexLife Price Match Guarantee†
Keep your price.
Upgrade your care.
Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.
Tirzepatide in Maryland: your questions
Fair questions about NexLife
- Will my price go up with my dose?
- No. You pay the same at every dose.
- What if I’m not prescribed?
- You aren’t charged for medication.
- Can I cancel?
- Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
- Do I need insurance?
- No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.
Does Maryland Medicaid cover Zepbound for weight loss?
No, not for weight loss alone. Since Feb. 5, 2025, Maryland Medicaid has covered Zepbound with prior authorization for adults with obesity (a BMI of 30 or more) and moderate to severe obstructive sleep apnea confirmed by a sleep test. A sleep specialist, pulmonologist or other experienced provider must prescribe it or consult.
Does Maryland's state employee plan cover Zepbound?
Not for weight loss. The State of Maryland's employee and retiree prescription plan lists weight loss drugs among its exclusions in both its 2026 and 2027 benefit guides.
Will Maryland Medicaid cover weight-loss drugs in 2027?
Possibly. Chapter 866 of 2026, in effect since Oct. 1, 2026, lets Maryland Medicaid offer comprehensive obesity treatment coverage starting Jan. 1, 2027, but doesn't require it. Until the Maryland Department of Health announces a change, weight-loss-only prescriptions aren't covered, so ask Medicaid or your HealthChoice plan before you fill one.
Is compounded tirzepatide legal in Maryland?
It can be, when it's compounded for you. Federal rules require a prescription for an individual patient, and since the FDA found the tirzepatide shortage resolved on Dec. 19, 2024, copies of Zepbound can't be made regularly unless your prescriber documents a significant difference for you. Maryland's Board of Pharmacy disciplines pharmacies that break its rules. It isn't FDA-approved.
Does my tirzepatide prescriber need a Maryland license?
Yes. The Maryland Board of Physicians says physicians must be licensed in Maryland to treat patients in Maryland, including by telehealth, and a Maryland license covers telehealth without any further Board approval. You can check a physician on the Board's Look Up A Licensee tool.
Can a pharmacy in another state ship tirzepatide to Maryland?
Yes, with a Maryland nonresident pharmacy permit. The pharmacy needs a Maryland-licensed pharmacist responsible for Maryland patients and a toll-free number. If it sends compounded sterile drugs like tirzepatide injections, it must follow USP standards and Maryland's sterile compounding rules. You can verify any pharmacy on the Board of Pharmacy's website.
How do I keep tirzepatide cold in a Maryland summer?
Put it in the fridge as soon as it arrives. Zepbound's label allows up to 21 days unrefrigerated, but never above 86°F, so don't leave a box on a hot porch. A compounded vial follows its own pharmacy label. If a package arrives warm, call the pharmacy before you use it.
How much does tirzepatide cost in Maryland without insurance?
Compounded tirzepatide costs $139 to $399 a month in our price index, all in, median $237 (checked Nov. 1, 2026). LillyDirect’s Zepbound is $299 to $449 a month; the $449 price from 7.5 mg needs a refill within 45 days, or it's $499 to $699. At NexLife, it's $139 a month on the 12-month plan or $169 month to month.
Where can I get tirzepatide in Baltimore or Silver Spring?
You don't need a clinic nearby. A Maryland-licensed provider can treat you online, and a pharmacy with a Maryland permit can ship to your door in Baltimore, Silver Spring or anywhere else in the state. If you'd rather go in person, look up the prescriber on the Board of Physicians' Look Up A Licensee tool first.
Can I appeal if my Maryland plan denies Zepbound?
Yes. Appeal to your plan first. If the plan is subject to Maryland law and says the drug isn't medically necessary, you can file a complaint with the Maryland Insurance Administration within four months of the plan's grievance decision. The Attorney General's Health Education and Advocacy Unit helps with appeals free of charge.
IN YOUR STATE
Not in Maryland? Pick your state
Tap your state on the map for its guide.
- Available through NexLife
- You’re here
- Selected
Maryland (you’re here): compounded tirzepatide is available through NexLife, $139/mo on the 12-month plan or $169 month to month, the same at every dose.
Compounded medications aren’t FDA-approved. A licensed provider prescribes one only when it offers a significant difference for you.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at
† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. NexLife is offered only in states where our affiliated providers are licensed.
Who wrote and checked this page
Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.
Prices checked November 1, 2026; Maryland rules checked October 25 to November 1, 2026, source by source.
- How we checked. Prices come from each company’s own site, checked November 1, 2026; state facts from the agencies and sources listed below. “All in” means medication plus any membership or program fee you must pay. Brand-name Zepbound is listed separately from compounded tirzepatide.
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
Paying less elsewhere? We match it.†
A price that stays put as your dose rises.
Compounded tirzepatide through NexLife costs $139 a month if you choose 12 months, or $169 if you go month to month. A licensed provider evaluates you before anything is prescribed.
4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.
- 1Tell us about you
Start online with your health history.
- 2A licensed provider decides
A licensed provider reviews your health history and decides whether treatment is right for you, following your state’s rules. You’re prescribed only if it is.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.
Sources
- KFF: Medicaid coverage of
GLP-1s for obesity, January 2026. Read November 1, 2026. - Maryland Department of Health: Wegovy or Zepbound prior authorization form (December 2025). Read November 1, 2026.
- State of Maryland: 2026 Health Benefits Guide (employees and retirees). Read November 1, 2026.
- COMAR 10.34.37: pharmacy permit holder and nonresident pharmacy operations (Maryland Board of Pharmacy). Read October 19, 2026; checked again October 25, 2026.
- Maryland Board of Pharmacy. Read November 1, 2026.
- CDC: Adult Obesity Prevalence Maps, 2025. Read November 1, 2026.
- Md. Code, Health Occupations § 12-403: nonresident pharmacies. Read November 1, 2026.
- PreventiveMD: compounded tirzepatide prices. Checked November 1, 2026.
- Mochi Health: compounded tirzepatide prices. Checked November 1, 2026.
- Rx.com: compounded tirzepatide prices. Checked November 1, 2026.
- Noom: compounded tirzepatide prices. Checked November 1, 2026.
- Remedy Meds: compounded tirzepatide prices. Checked November 1, 2026.
- Ondra Health: compounded tirzepatide prices. Checked November 1, 2026.
- NexLife: compounded tirzepatide plans. Checked November 1, 2026.
- LillyDirect: Zepbound self-pay pricing. Checked November 1, 2026.
- Ro: membership and medication pricing. Checked November 1, 2026.
- Hims: Zepbound KwikPen and membership. Checked November 1, 2026.
- FDA: Compounding and the FDA, questions and answers.
- Zepbound (tirzepatide) Prescribing Information, Eli Lilly.
- Hims: Wegovy pill and pen, with membership. Checked November 1, 2026.
- Embody: compounded tirzepatide, one-month supply. Checked November 1, 2026.
- Embody: compounded semaglutide, one-month supply. Checked November 1, 2026.
- Maryland General Assembly: SB 496 (2026), Chapter 866, Medicaid coverage for the treatment of obesity. Checked November 1, 2026.
- COMAR 10.32.05.05: telehealth patient evaluation (Maryland Board of Physicians). Checked November 1, 2026.
- COMAR 10.32.05.06: standards related to telehealth. Checked November 1, 2026.
- Maryland Board of Pharmacy: nonresident pharmacy application (inspection reports). Seen November 1, 2026.
- Maryland Board of Pharmacy: license and permit lookup. Seen November 1, 2026.
- Bipartisan letter from 38 attorneys general on counterfeit
GLP-1 drugs (Tennessee Attorney General’s office, February 20, 2025). Seen November 1, 2026. - BWI Marshall Airport monthly highs, 1991–2020 climate normals (NOAA). Seen November 1, 2026.
- Maryland Department of Health, Maryland Medical Assistance Program. PT 35-25: Coverage of Wegovy for Overweight or Obese Adults with Cardiovascular Disease, Effective September 15, 2024. Sept. 13, 2024 (effective Sept. 15, 2024).
- Maryland Medical Assistance Program (copy posted by Aetna Better Health, a HealthChoice MCO). PT 74-25: Notice of Zepbound Coverage Effective February 5, 2025. April 14, 2025 (effective Feb. 5, 2025).
- Maryland Department of Legislative Services. Fiscal and Policy Note (Enrolled, Revised), SB 496: Maryland Medical Assistance Program – Coverage for the Treatment of Obesity – Authorization. April 11, 2026.
- Maryland General Assembly. SB 496 (2026), enrolled bill (Chapter 866). Chapter 866; effective Oct. 1, 2026.
- Maryland General Assembly. SB0496 (2026 Regular Session) bill page: Chapter 866, enacted May 31, 2026. May 31, 2026 (enacted).
- Maryland Department of Health. Maryland Medical Assistance Program – Coverage for the Treatment of Obesity – Required Study (Chapters 777 and 778 of the Acts of 2024). December 2024 (cover letter Jan. 31, 2025).
- Maryland Department of Budget and Management, Employee Benefits Division. State of Maryland 2027 Guide to Your Health Benefits. Plan year Jan. 1-Dec. 31, 2027 (file dated Oct. 3, 2026).
- Maryland Department of Legislative Services. Fiscal and Policy Note, HB 1031 (2025 Session): Health Insurance – Required Coverage – Prescription Weight Loss Drugs. 2025 session.
- Maryland Insurance Administration. Understanding Your Health Insurance Coverage. Read Nov. 2, 2026.
- Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge, overview and FAQs.
- TRICARE. TRICARE coverage of weight loss medications: what to know (Aug. 5, 2025).
- Maryland Insurance Administration. Appeals and Grievance. Read Nov. 2, 2026.
- Maryland General Assembly. SB 402 (2020), Health Care Practitioners – Telehealth and Shortage (enrolled bill; adds Health Occ. § 1-1003). 2020 session (emergency bill).
- Maryland Board of Physicians. FAQs For Telehealth. Aug. 15, 2021.
- Maryland Board of Physicians. Interstate Medical Licensure Compact (IMLC). Read Nov. 2, 2026.
- Maryland Board of Physicians. Verification of licensure (consumer page; links Look Up A Licensee at mbp.state.md.us/bpqapp/). Read Nov. 2, 2026.
- Maryland Department of Legislative Services. Fiscal and Policy Note, HB 999 (2015 Session): nurse practitioners. 2015 session (enacted as Chapter 468 of 2015).
- Code of Maryland Regulations (Division of State Documents). COMAR 10.27.07.02, Certification (nurse practitioners). No date shown; read Nov. 2, 2026.
- Maryland Board of Physicians. Physician Assistant Modernization Act of 2024 Highlights. Read Nov. 2, 2026.
- Maryland Board of Pharmacy. Application for Non-Resident Pharmacy Permit (with instructions). Revised Nov. 10, 2021.
- Maryland Board of Pharmacy. Consumer Information (Online Services: License Verification link to mdbop.mylicense.com/Verification). Read Nov. 2, 2026.
- Maryland Board of Pharmacy. Consent Order, Case No. 25-422B (Maryland nonresident permit P05923). 2026 (file dated 7-7-2026; charges issued April 15, 2026).
- U.S. Court of Appeals for the Fifth Circuit. Outsourcing Facilities Association v. FDA, No. 25-10600 (Aug. 27, 2026).
- Centers for Medicare & Medicaid Services (Medicare.gov). Medicare GLP-1 Bridge: GLP-1 Drugs for $50 a Month (CMS Product No. 12234). June 2026.
- U.S. Food and Drug Administration. FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List. April 30, 2026.